Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: Comparing One Versus Two Doses of Psilocybin

Recruiting

Phase 2

Psilocybin vs. PsilocybinPsilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: Comparing One Versus Two Doses of Psilocybin

Sponsor:

University Health Network, Toronto

Code:

NCT06341426

Conditions

Major Depressive Disorder

Depression

Treatment-Resistant Depression

Mood Disorders

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Single Psychedelic Dose Psilocybin

Two Psychedelic Doses Psilocybin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-22. This information was provided to ClinicalTrials.gov by University Health Network, Toronto on 2024-04-02.